CSL Limited
CSL
Rank in Stocks
#368
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Share Price
$137.10
Market Cap
$65.79B
Change (1 day)
0.34%
Change (1 year)
-4.29%
Country
AU
Trade CSL Limited (CSL)
Category
Healthcare
Stock price history for CSL Limited (CSL)
Highest end of day price: $130.89 on 2026-10-01
Lowest end of day price: $0.58 on 1994-05-01
Lowest end of day price: $0.58 on 1994-05-01
Stock price history of CSL Limited from 1994 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -11.03% |
| 2025 | -33.22% |
| 2024 | -3.40% |
| 2023 | -7.34% |
| 2022 | -5.55% |
| 2021 | -4.35% |
| 2020 | 13.64% |
| 2019 | 48.92% |
| 2018 | 19.64% |
| 2017 | 51.86% |
| 2016 | -2.99% |
| 2015 | 3.42% |
| 2014 | 17.66% |
| 2013 | 7.48% |
| 2012 | 72.89% |
| 2011 | -9.64% |
| 2010 | 27.38% |
| 2009 | 31.88% |
| 2008 | -30.73% |
| 2007 | 91.54% |
| 2006 | 59.34% |
| 2005 | 39.55% |
| 2004 | 69.88% |
| 2003 | 10.97% |
| 2002 | -54.53% |
| 2001 | 23.69% |
| 2000 | 47.80% |
| 1999 | 54.18% |
| 1998 | 35.94% |
| 1997 | 57.11% |
| 1996 | 56.41% |
| 1995 | 57.26% |
| 1994 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
|
| $1.05K | -16.55% |
KR
|
